JSF Financial LLC Invests $216,000 in Intuitive Surgical, Inc. $ISRG

JSF Financial LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 397 shares of the medical equipment provider’s stock, valued at approximately $216,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Chilton Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares in the last quarter. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at $26,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical in the first quarter valued at about $30,000. TD Capital Management LLC lifted its stake in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares in the last quarter. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. UBS Group increased their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. BTIG Research reaffirmed a “buy” rating and issued a $571.00 target price on shares of Intuitive Surgical in a research report on Wednesday. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Finally, Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday. Fourteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $594.19.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $452.35 on Friday. The business’s fifty day moving average price is $463.55 and its two-hundred day moving average price is $500.06. The company has a market capitalization of $162.16 billion, a P/E ratio of 63.09, a PEG ratio of 4.74 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same period last year, the company earned $1.78 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.